|
May 15
|
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
|
|
May 8
|
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2024 Earnings Call Transcript
|
|
May 8
|
OrthoPediatrics First Quarter 2024 Earnings: Beats Expectations
|
|
May 8
|
OrthoPediatrics Corp (KIDS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
|
|
May 8
|
Q1 2024 OrthoPediatrics Corp Earnings Call
|
|
May 6
|
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 6
|
OrthoPediatrics Corp (KIDS) Q1 2024 Earnings: Revenue Surges, Outperforming Analyst Forecasts
|
|
May 6
|
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 6
|
OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
|
|
May 2
|
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
|
|
Apr 22
|
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
|
|
Apr 4
|
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
|
|
Mar 26
|
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 12
|
OrthoPediatrics Corp. (NASDAQ:KIDS) Q4 2023 Earnings Call Transcript
|
|
Mar 8
|
Q4 2023 OrthoPediatrics Corp Earnings Call
|
|
Mar 7
|
OrthoPediatrics Corp (KIDS) Reports Robust Revenue Growth and Improved Adjusted EBITDA in 2023
|
|
Mar 6
|
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Mar 6
|
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 6
|
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
|
|
Mar 4
|
OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
|